Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-31
1999-11-02
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, 514962, 514960, 514970, 514973, 424451, 424452, 424464, 424465, 424489, A01N 4342, A61K 3144
Patent
active
059771275
ABSTRACT:
Solid and liquid pharmaceutical preparations containing cilansetron or its acid addition salts as active substance which include an amount sufficient to stabilize cilansetron against racemization, of a physiologically compatible water-soluble acid additive selected from monobasic or multibasic organic acids having 2 to 12 carbon atoms with a first p.sub.s value between 1.1 and 4.8, acid salts of the aforementioned multibasic organic acids, and acid salts of multibasic mineral acids having a first available pK.sub.s value between 1.5 and 7.5, as well as the use of such acid additives for stabilizing cilansetron against racemization in pharmaceutical preparations.
REFERENCES:
patent: 4939136 (1990-07-01), Haeck et al.
patent: 5438068 (1995-08-01), Eeckhout et al.
patent: 5663343 (1997-09-01), van der Meij et al.
Bonnacker Ingo
Koehn Hartmut
Kristen Gerhard
Reichel Christine
Krass Frederick
Solvay Pharmaceuticals GmbH
LandOfFree
Cilansetron pharmaceutical preparation stabilized against racemi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cilansetron pharmaceutical preparation stabilized against racemi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cilansetron pharmaceutical preparation stabilized against racemi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135824